FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LERAMISTAT
异名/同义词(1,1'-BIPHENYL)-4-SULFONAMIDE, 4'-CHLORO-2'-CYANO-N-(TRANS-4-HYDROXY-4-METHYLCYCLOHEXYL)-
1-METHYL-TRANS-4-(((4'-CHLORO-2'-CYANO-1,1'-BIPHENYL-4-YL)SULFONYL)AMINO)CYCLOHEXANOL
4'-CHLORO-2'-CYANO-N-((1R,4R)-4-HYDROXY-4-METHYLCYCLOHEXYL)(1,1'-BIPHENYL)-4-SULFONAMIDE
4'-CHLORO-2'-CYANO-N-(TRANS-4-HYDROXY-4-METHYLCYCLOHEXYL)-BIPHENYL-4-SULFONAMIDE
HMC-C-01-A
LERAMISTAT
LERAMISTAT [INN]
MBS-2320
CAS登记号1642602-54-7
物质唯一标识(Unique Ingredient Identifier)38E2HYD3AW
分子式C20H21ClN2O3S
国际化合物标识(International Chemical Identifier,InChI)PHOYDFRXZMNHIF-IRJFHVNHSA-N
SMILESC[C@]1(O)CC[C@@H](CC1)NS(=O)(=O)c2ccc(cc2)-c3c(cc(Cl)cc3)C#N
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System